 |
|
|
REFERENCES
1.
Nuttall GA, Stehling LC, Beighley CM, et al: Current
transfusion practices of members of the American Society of Anesthesiologists. Anesthesiology
99:1433, 2003.
2.
ASA Task Force: Practice guidelines for blood component
therapy. Anesthesiology 84:32, 1996.
3.
Royal College of Physicians of Edinburgh: Consensus
statement on red cell transfusion. Br J Anaesth 73:857, 1994.
4.
Miller RD, Stehling L: What is the transfusion
trigger? What is the message? Anesthesiology 86:750, 1997.
5.
National Institutes of Health Consensus Development
Conference Statement: Perioperative red cell transfusion. Am J Public Health 78:1588,
1988.
6.
Sehgal LR, Zebala LP, Takagi I, et al: Evaluation
of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery
bypass graft surgery patients. Transfusion 41:591, 2001.
7.
Domen RE: Adverse reactions associated with autologous
blood transfusions. Transfusion 38:296, 1998.
8.
Marik PE, Sibbald WJ: Effect of stored-blood transfusion
on oxygen delivery in patients with sepsis. JAMA 269:3024, 1993.
9.
Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion
in the ICU: Is there a reason? Chest 108:767, 1995.
10.
Hébert PC, Wells G, Marshall J, et al, for
the Canadian Critical Care Trials Group: Transfusion requirements in critical care—A
pilot study. JAMA 273:1439, 1995.
11.
Bishop MH, Shoemaker WC, Appel PL, et al: Relationship
between supranormal circulatory values, time delays and outcome in severely traumatized
patients. Crit Care Med 21:56, 1993.
12.
Bishop MH, Shoemaker WC, Appel PL, et al: Prospective,
randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen
consumption as resuscitation endpoints in severe trauma. J Trauma Injury Infect
Crit Care 38:780, 1995.
13.
Boyd O, Grounds RM, Bennett DE: A randomized clinical
trial of the effect of deliberate perioperative increase of oxygen delivery on mortality
in high-risk surgical patients. JAMA 270:2699, 1993.
14.
Purdy RF, Tweeddale MG, Merrick PM: Association
of mortality with age of blood transfused in septic ICU patients. Can J Anaesth
44:1256, 1997.
15.
Vamvakas EC, Carven JH: Transfusion and postoperative
pneumonia in coronary artery bypass surgery: Effect of the length of storage of
transfused red cells. Transfusion 39:701, 1999.
16.
Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL,
et al: Influence of erythrocyte concentrate storage time on postsurgical morbidity
in cardiac surgery patients. Anesthesiology 98:815, 2003.
17.
Kim DM, Brecher ME, Estes TJ, et al: Relationship
of hemoglobin level and duration of hospitalization after total hip arthroplasty:
Implications for the transfusion target. Mayo Clin Proc 68:37, 1993.
18.
Thurer RL: Evaluating transfusion triggers. JAMA
279:238, 1998.
19.
Weiskopf RB, Viele MK, Feiner J, et al: Human
cardiovascular and metabolic responses to acute, severe isovolemic anemia. JAMA
279:217, 1998.
20.
Habibi S, Corrsin DB, McDermott JC, et al: Trauma
and massive hemorrhage. In Muravchick S, Miller
RD (eds): Atlas of Anesthesia: Subspecialty Care. New York, Churchill Livingstone,
1998, pp. 6.2–6.17.
21.
Hebert PC, Wells G, Blajchman MA, et al: A multicenter,
randomized, controlled clinical trial of transfusion requirements in critical care.
N Engl J Med 340:409, 1999.
22.
Ely EW, Bernard GR: Transfusions in critically
ill patients. N Engl J Med 340:467, 1999.
23.
Hebert PC, Fergusson DA: Red blood cell transfusions
in critically ill patients. JAMA 288:1525, 2002.
24.
Vincent JL, Baron JF, Reinhart K, et al: Anemia
and blood transfusion in critically ill patients. JAMA 288:1499, 2002.
25.
Wu WC, Rathore SS, Wang Y, et al: Blood transfusion
in elderly patients with acute myocardial infarction. N Engl J Med 345:1230, 2001.
26.
Hebert PC, Yetisic E, Martin C, et al: Is a low
transfusion threshold safe in critically ill patients with cardiovascular disease
safe? Crit Care Med 29:227, 2001.
27.
van Klei WA, Moons KG, Leyssius AT, et al: A reduction
in type and screen: Preoperative prediction of RBC transfusion in surgery procedures
with intermediate transfusion risks. Br J Anaesth 87:250, 2001.
28.
Walsh TS, McClelland DBL: When should we transfuse
critically ill and perioperative patients with known coronary artery disease? Br
J Anaesth 90:709, 2003.
29.
McCrossan L, Masterson G: Blood transfusion in
critical illness. Br J Anaesth 88:6, 2002.
30.
Saxena S, Wehrli G, Makarewicz K, et al: Monitoring
for underutilization of RBC components and platelets. Transfusion 41:587, 2001.
31.
Weiskopf RB: Do we know when to transfuse red
cells to treat acute anemia? Transfusion 38:517, 1998.
32.
Renner SW, Howanitz PJ, Bachner P: Preoperative
autologous blood donation in 612 hospitals: A College of American Pathologists'
Q-probes study of quality issues in transfusion practice. Arch Pathol Lab Med 116:613,
1992.
33.
Etchason J, Petz L, Keeler E, et al: The cost
effectiveness of preoperative autologous blood donations. N Engl J Med 332:719,
1995.
34.
Kanter MH, Van Maanen D, Anders KH, et al: Preoperative
autologous blood donations before elective hysterectomy. JAMA 276:798, 1996.
35.
Popovsky MA, Whitaker B, Arnold NL: Severe outcomes
of allogeneic and autologous blood donations: Frequency and characterization. Transfusion
35:734, 1995.
36.
Centers for Disease Control and Prevention (CDC):
Red blood cell transfusions contaminated with Yersinia enterocolitica.
JAMA 278:553, 1997.
37.
Williams AE, Thompson RA, Schreiber GB, et al:
Estimates of infectious disease risk factors in US blood donors. JAMA 277:967,
1997.
38.
Miller RD, Von Ehrenberg W: Should the same indication
be used for both autologous and homologous transfusions? Transfusion 35:703, 1995.
39.
American Society of Anesthesiologists: Transfusion
Practices: Questions and Answers, 3rd ed. Chicago, American Society of Anesthesiologists,
1998, pp 8–9.
40.
Boyd PR, Sheedy KC, Henry JB: Type and screen:
Use and effectiveness in elective surgery. Am J Clin Pathol 74:694, 1980.
41.
Oberman AJ, Barnes BA, Friedman BA: The risk of
abbreviating the major crossmatch in urgent or massive transfusion. Transfusion
18:137, 1978.
42.
Sarma DP: Use of blood in elective surgery. JAMA
243:1536, 1980.
43.
Friedman BA: An analysis of surgical blood use
in United States hospitals with application to the maximum surgical blood order schedule.
Transfusion 19:268, 1979.
44.
Walker RH: What is a clinically significant antibody?
In Polesky HF, Walker RH (eds): Safety and Transfusion
Practices. Skokie, IL, College of American Pathologists, 1982, p 79.
45.
Gervin AS, Fischer RP: Resuscitation of trauma
patients with type-specific uncrossmatched blood. J Trauma 24:327, 1984.
46.
Moore GL, Peck CC, Sohmer PR, et al: Some properties
of blood stored in CPDA-1 solution. Transfusion 21:135, 1981.
47.
Valeri CR: Measurement of viable ADSOL-preserved
human red cells. N Engl J Med 312:377, 1985.
48.
Vovric VA, Archer GT, Wisdom L, et al: Thirty-five-day
modified red cells and 7-day stored platelet concentrates from triple bags of identical
PVC formation. Vox Sang 49:181, 1985.
49.
Valeri CR: Simplification of the methods for adding
and removing glycerol during freeze-preservation of human red blood cells with high
or low glycerol methods: Biochemical modification prior to freezing. Transfusion
15:195, 1975.
50.
Telischi M, Hoiberg R, Rao KPP, et al: The use
of frozen, thawed erythrocytes in blood banking. Am J Clin Pathol 68:250, 1977.
51.
Valtis DJ, Kennedy AC: Defective gas-transport
function of stored red blood cells. Lancet 1:119, 1954.
52.
Kopriva CJ, Ratliff JL, Fletcher JR, et al: Biochemical
and hematological changes associated with massive transfusion of ACD-stored blood
in severely injured combat casualties. Ann Surg 176:585, 1972.
53.
McConn R, Derrick JB: The respiratory function
of blood: Transfusion and blood storage. Anesthesiology 36:119, 1972.
54.
Sheldon GF: Diphosphoglycerate in massive transfusion
and erythropheresis. Crit Care Med 7:407, 1979.
55.
Valeri CR, Collins FB: Physiologic effects of
2,3-DPG-depleted red cells with high affinity for oxygen. J Appl Physiol 31:823,
1971.
56.
Bowen JC, Fleming WH: Increased oxyhemoglobin
affinity alters transfusion of stored blood: Evidence for circulatory compensation.
Ann Surg 180:760, 1974.
57.
Collins JA: Recent developments in the area of
massive transfusion. World J Surg 11:75, 1987.
58.
Miller RD, Robbins TO, Tong MJ, et al: Coagulation
defects associated with massive blood transfusions. Ann Surg 174:794, 1971.
59.
Counts RB, Haisch C, Simon TL, et al: Hemostasis
in massively transfused trauma patients. Ann Surg 190:91, 1979.
60.
Reed RL, Heimback DM, Counts RB, et al: Prophylactic
platelet administration during massive transfusion. Ann Surg 203:40, 1986.
61.
Miller RD: Complications of massive blood transfusions.
Anesthesiology 39:82, 1973.
62.
NIH Consensus Conference: Fresh frozen plasma:
Indications and risks. JAMA 253:551, 1985.
63.
Levi M, ten Cate H, van der Poll T, van Deventer
JH: Pathogenesis of disseminated intravascular coagulation. JAMA 270:975, 1993.
64.
Attar S, Hanashiro P, Mansberger A: Intravascular
coagulation: Reality or myth. Surgery 68:27, 1970.
65.
Corrigan JJ, Jordan CM: Heparin therapy in septicemia
with disseminated intravascular coagulation. N Engl J Med 283:778, 1970.
66.
Priano LL, Wilson RD, Traber DL: Lack of significant
protection afforded by heparin during endotoxic shock. Am J Physiol 220:901, 1971.
67.
Mant MJ, King EG: Severe, acute disseminated intravascular
coagulation. Am J Med 67:557, 1979.
68.
Fourrier F, Chopin C, Goudemand J, et al: Septic
shock, multiple organ failure, and disseminated intravascular coagulation. Chest
101:816, 1992.
69.
Saleem A, Blifeld C, Saleh SA, et al: Viscoelastic
measurement of clot formation: A new test of platelet function. Ann Clin Lab Sci
13:115, 1983.
70.
Lavee J, Martinowitz U, Mohr R, et al: The effect
of transfusion of fresh whole blood versus platelet concentrates after cardiac operations.
J Thorac Cardiovasc Surg 97:204, 1989.
71.
Erber WN, Tan J, Grey D, et al: Use of unrefrigerated
fresh whole blood in massive transfusion. Med J Aust 165:11, 1996.
72.
Harvey MP, Dwyer P, Dean MG: Fighting a rearguard
action in the massively transfused patient. Med J Anest 165:9, 1996.
73.
Murray DJ, Olson J, Strauss R, Tinker JH: Coagulation
changes during packed red cell replacement of major blood loss. Anesthesiology 69:839,
1988.
74.
Kang Y, Lewis JH, Navalgung A, et al: Epsilon-aminocaproic
acid for treatment of fibrinolysis during liver transplantation. Anesthesiology
66:766, 1987.
75.
Weiskoph RB: Intraoperative use of recombinant
activated coagulation factor VII. Anesthesiology 96:1287, 2002.
76.
Morgan PD, Hosking MP: The role of desmopressin
acetate in patients undergoing coronary artery bypass surgery. Anesthesiology 77:38,
1992.
77.
Feeley TW, Rinsky LA: Use of aprotinin to reduce
intraoperative bleeding. West J Med 159:189, 1993.
78.
Hüppala S, Strid L, Wennerstrand M, et al:
Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total
knee arthroplasty. Br J Anaesth 74:534, 1995.
79.
Hüppala ST, Strid LJ, Wennerstrand MI, et
al: Tranexamic acid radically decreases blood loss and transfusions associated with
total knee arthroplasty. Anesth Analg 84:839, 1997.
80.
Laupacis A, Fergusson D, for the International
Study of Perioperative Transfusion Investigators: Drugs to minimize perioperative
blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion
as the outcome. Anesth Analg 85:1258, 1997.
81.
Leslie SD, Toy PT: Laboratory hemostatic abnormalities
in massively transfused patients given red blood cells and crystalloid. Am J Clin
Pathol 96:770, 1991.
82.
Urban P, Scheidegger D, Buchmann B, et al: Cardiac
arrest and blood ionized calcium levels. Ann Intern Med 109:110, 1988.
83.
Drop LJ, Laver MB: Low plasma ionized calcium
and response to calcium therapy in critically ill man. Anesthesiology 43:300, 1975.
84.
Bashour TT, Ryan C, Kabbani SS, et al: Hypocalcemic
acute myocardial failure secondary to rapid transfusion of citrated blood. Am Heart
J 108:1040, 1984.
85.
Linko K, Tigerstedt I: Hyperpotassemia during
massive blood transfusions. Acta Anaesthesiol Scand 28:220, 1984.
86.
Morris RH: Influence of ambient temperature on
patient temperature during intra-abdominal surgery. Ann Surg 173:230, 1971.
87.
Zorko MF, Polsky SS: Rapid warming and infusion
of packed red blood cells. Ann Emerg Med 15:907, 1986.
88.
Sazama K: Reports of 355 transfusion-associated
deaths: 1976 through 1985. Transfusion 30:583, 1990.
89.
Iserson KV, Huestis DW: Blood warming: Current
application and techniques. Transfusion 31:558, 1991.
90.
Collins JA, Simmons RL, James PM, et al: The acid-base
status of seriously wounded combat casualties. I. Resuscitation with stored blood.
Ann Surg 173:6, 1971.
91.
Miller RD, Tong MJ, Robbins TO: Effects of massive
transfusion of blood on acid-base balance. JAMA 216:1762, 1971.
92.
France CJ, Eger EI II, Bendixen HH: The use of
peripheral venous blood for pH and carbon dioxide tension determinations during general
anesthesia. Anesthesiology 40:311, 1974.
93.
Wong DW, Mishkin FS, Tanaka TT: The effects of
bicarbonate on blood coagulation. JAMA 244:61, 1980.
94.
Moseley RV, Doty DB: Changes in the filtration
characteristics of stored blood. Ann Surg 171:329, 1970.
95.
Gilbert GL: Prevention of transfusion-acquired
cytomegalovirus infection in infants by blood filtration to remove leukocytes. Lancet
1:1228, 1989.
96.
Hässig A, Collins JA, Högman C, et al:
When is microfiltration of whole blood and red cell concentrates essential? When
is it superfluous? Vox Surg 50:54, 1986.
97.
Kopko PM, Holland PV: Mechanism of severe transfusion
reactions. Transfusion Clin Biol 8:278, 2001.
98.
Capon SM, Sacher RA: Hemolytic transfusion reactions:
A review of mechanisms, sequelae, and management. J Intensive Care Med 4:100, 1989.
99.
Linden JV, Tourault MA, Schribner CL: Decrease
in frequency of transfusion fatalities. Transfusion 37:243, 1997.
100.
Seyfried H, Walewska I: Immune hemolytic transfusion
reactions. World J Surg 11:25, 1987.
101.
Huh YO, Lichtiger B: Transfusion reactions in
patients with cancer. J Clin Pathol 87:253, 1987.
102.
Pineda AA, Brzica SM Jr, Taswell HF: Hemolytic
transfusion reaction. Mayo Clin Proc 53:378, 1978.
103.
Lopas H: Immune hemolytic transfusion reactions
in monkeys: Activation of the kallikrein system. Am J Physiol 225:372, 1973.
104.
Seager OA, Nesmith MA, Begelman KA, et al: Massive
acute hemodilution for incompatible blood reaction. JAMA 229:788, 1974.
105.
Solanki D, McCurdy PR: Delayed hemolytic transfusion
reactions: An often-missed entity. JAMA 239:729, 1978.
106.
Hewitt PE, Macintyre EA, Devenish A, et al: A
prospective study of the incidence of delayed haemolytic transfusion reactions following
perioperative blood transfusion. Br J Haematol 69:541, 1988.
107.
Poipvsky MS, Abel MD, Moore SB: Transfusion-related
acute lung injury associated with passive transfer of anti-leukocyte antibodies.
Am Rev Respir Dis 128:185, 1983.
108.
Oberman HA: Controversies in transfusion medicine:
Should a febrile transfusion response occasion the return of the blood component
to the blood bank? Con Transfusion 34:353, 1994.
109.
Widman FK: Controversies in transfusion medicine:
Should a febrile transfusion response occasion the return of the blood component
to the blood bank? Pro Transfusion 34:356, 1994.
110.
Busch MP, Kleinman SH, Nemo GJ: Current and emerging
infectious risks of blood transfusions. JAMA 289:959, 2003.
111.
Tong MJ, El-Farra NS, Reikes AR, et al: Clinical
outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463, 1995.
112.
Murphy EL, Bryzman S, Williams AE, et al: Demographic
determinants of hepatitis C virus seroprevalence among blood donors. JAMA 275:995,
1996.
113.
Curran JW, Lawrence DN, Jaffe H, et al: Acquired
immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med 310:69,
1984.
114.
Simon TL, Bankhurst AD: A study of surrogate
tests to prevent transmission of acquired immunodeficiency syndrome. Blood 62(Suppl
1):238a, 1984.
115.
Ballas SK, Draper EK, Harris M, et al: Designated
blood donations. N Engl J Med 310:124, 1984.
116.
Cohen ND, Muñoz A, Reitz BA, et al: Transmission
of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery.
N Engl J Med 320:1173, 1989.
117.
Preiksaitis VK, Grumet FC, Smith WK, et al: Transfusion-acquired
cytomegalovirus infection in cardiac surgery patients. J Med Virol 15:283, 1985.
118.
Preiksaitis JK, Brown L, McKenzie M: The risk
of cytomegalovirus infection in seronegative transfusion recipients not receiving
exogenous immunodepression. J Infect Dis 157:523, 1988.
119.
Pealer LN, Marfin AA, Petersen LR, et al: Transmission
of West Nile virus through blood transfusions in the United States in 2002. N Engl
J Med 349:1236, 2003.
120.
Wilhelm JA, Matter L, Schopfer K: The risk of
transmitting cytomegalovirus to patients receiving blood transfusions. J Infect
Dis 154:169, 1986.
121.
Tripple MA, Bland JJ, Murphy MJ, et al: Sepsis
associated with transfusion of red cells contaminated with Yersinia
enterocolitica. Transfusion 30:207, 1990.
122.
Aber RC: Transfusion-associated Yersinia
enterocolitica. Transfusion 30:193, 1990.
123.
Grossman BJ, Kollins PM, Lau JL, et al: Screening
blood donors for gastrointestinal illness: A strategy to eliminate carriers of Yersinia
enterocolitica. Transfusion 31:500, 1991.
124.
Glynn SA, Busch MP, Schreiber GB, et al: Effect
of a national disaster on blood supply and safety. JAMA 289:2246, 2003.
125.
Hayashi H, Nishiuchi T, Tamura H, et al: Transfusion-associated
graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology
79:1419, 1992.
126.
Kopko PM, Marshall CS, MacKenzie MR, et al: Transfusion-related
acute lung injury. JAMA 287:1968, 2002.
127.
Florell SR, Velasco SE, Fine PG: Perioperative
recognition, management, and pathologic diagnosis of transfusion-related acute lung
injury. Anesthesiology 81:508, 1994.
128.
Centers for Disease Control and Prevention: Adverse
ocular reactions following transfusion—United States 1997–1998. JAMA
279:49, 1998.
129.
Landers DF, Hill GE, Wong KC, et al: Blood transfusion-induced
immunomodulation. Anesth Analg 82:187, 1996.
130.
Vamvakas EC: Transfusion-related immunomodulation.
Transfusion Alternatives in Transfusion Med 4:48, 2002.
131.
Corwin HL, AuBuchon JP: Is leukoreduction of
blood components for everyone? JAMA 289:1993, 2003.
132.
Vamvakas EC, Blajchman MA: Universal WBC reduction:
A case for and against. Transfusion 41:691, 2001.
133.
Hebert PC, Fergusson DA, Blajchman MA, et al:
Clinical outcomes following institution of the Canadian Universal leukoreduction
program for red blood cell transfusions. JAMA 289:1941, 2003.
134.
Cull DL, Lally KP, Murphy KD: Compatibility of
packed erythrocytes and Ringer's lactate solution. Surg Gynecol Obstet 173:12, 1991.
135.
Brown WJ, Kim BS, Weeks DB, et al: Physiologic
saline solution, Normosol R pH 7.4, and Plasmanate as reconstituents of packed human
erythrocytes. Anesthesiology 49:99, 1978.
136.
Morrow JF, Braine HG, Kickler TS, et al: Septic
reactions to platelet transfusions. JAMA 266:255, 1991.
137.
Goodnough LT, Brecher ME, Kanter MH, et al: Transfusion
medicine. I. Blood transfusion. N Engl J Med 340:438, 1999.
138.
Mohr R, Goor DA, Yellin A, et al: Fresh blood
units contain large potent platelets that improve hemostasis after open heart operations.
Ann Thorac Surg 53:650, 1992.
139.
Kruskall MS: The perils of platelet transfusions.
N Engl J Med 337:1914, 1997.
140.
Jafari M, Forsberg J, Gilcher RO, et al: Salmonella
sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J
Med 347:1075, 2002.
141.
Snyder EL, Rinder HM: Platelet storage-time to
come in from the cold? N Engl J Med 348:2032, 2003.
142.
Brown B, Steed DL, Webster MW, et al: General
surgery in adult hemophiliacs. Surgery 99:154, 1986.
143.
White GC, McMillan CW, Kindon HS, et al: Use
of recombinant antihemophiliac factor in the treatment of two patients with classic
hemophilia. N Engl J Med 320:164, 1989.
144.
Goodnough LT, Brecher ME, Kanter MH: Transfusion
medicine. II. Blood conservation. N Engl J Med 340:525, 1999.
145.
Centers for Disease Control: Bacterial sepsis
associated with the receipt of albumin. JAMA 276:1373, 1996.
146.
Vincent JL, Wilkes MM, Navickis RJ: Safety of
human albumin—serious adverse events reported world wide in 1998–2002.
Br J Anaesth 91:625, 2003.
147.
Vermeulen LC, Ratko TA, Erstad BL, et al: The
university hospital consortium guidelines for the use of albumin, nonprotein colloid
and crystalloid solutions. Arch Intern Med 155:373, 1995.
148.
Boldt J: New light on intravascular volume replacement
regimens: What did we learn from the past three years? Anesth Analg 97:1595, 2003.
149.
Friedman Z, Berkenstadt H, Preisman S, et al:
A comparison of lactated Ringer's solution to hydroxy ethyl starch 6% in a model
of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg 96:39,
2003.
150.
Wilkes NJ, Woolf RL, Powanda MC, et al: Hydroxyethyl
starch in balanced electrolyte solution (Hextend)—Pharmacokinetic and pharmacodynamics
profiles in healthy volunteers. Anesth Analg 94:538, 2002.
151.
Markus R, Haller M, Orth V, et al: Changes in
blood volume and hematocrit during acute preoperative volume loading with 5% albumin
or 6% hetastarch solutions in patients before radical hysterectomy. Anesth Analg
95:849, 2001.
152.
Asfar P, Kerkeni N, Labadie F, et al: Assessment
of hemodynamic and gastric mucosal acidosis with modified fluid gelatin versus hydroxyethyl
starch. Intensive Care Med 26:1282, 2000.
153.
Hedin H, Richter W, Messmer K, et al: Incidence,
pathomechanism and prevention of dextran-induced anaphylactoid/anaphylactic reactions
in man. Biol Stand 48:179, 1980.
154.
Bernstein RL, Rosenberg AD, Pada EY, et al: A
severe reaction to dextran despite hapten inhibition. Anesthesiology 67:567, 1987.
155.
Ljungström KG, Renck H, Hedin H, et al:
Hapten inhibition and dextran anaphylaxis. Anaesthesia 43:729, 1988.
156.
Kreimeier V, Brückner UB, Niemczyk S, et
al: Hyperosmotic saline dextran for resuscitation from traumatic-hemorrhage hypotension.
Circ Shock 32:83, 1990.
157.
Behrman SW, Fabian TC, Kudsk KA, et al: Microcirculatory
flow changes after initial resuscitation of hemorrhagic shock with 7.5% hypertonic
saline/6% dextran 70. J Trauma 31:589, 1990.
158.
Brauer LP, Svensen CH, Hahn RG, et al: Influence
of rate and volume of infusion on the kinetics of 0.9 saline and 7.5% saline/dextran
70 in sheep. Anesth Analg 95:1547, 2002.
159.
Drobin D, Hahn RG: Kinetics of isotonic and hypertonic
plasma volume expanders. Anesth Analg 96:1371, 2002.
160.
Tremper KK, Friedman AE, Levine EM, et al: The
preoperative treatment of severely anemic patients with perfluorochemical oxygen
transport fluid, Fluosol-DA. N Engl J Med 307:277, 1982.
161.
Cheng DCH: Safety and efficacy of o-raffinose
cross-linked human hemoglobin (Hemolink) in cardiac surgery. Can J Anaesth 48:S41,
2001.
162.
Vogel WM, Dennis RC, Cassidy G, et al: Coronary
constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 251:H420, 1986.
163.
Looker D, Abbott-Brown D, Cozart P: A human recombinant
haemoglobin designed for use as a blood substitute. Nature 356:258, 1992.
164.
Levy J: The use of haemoglobin glutamer-250 (HBOC-201)
as an oxygen bridge in patients with acute anaemia associated with surgical blood
loss. Expert Opin Biol Ther 3:509, 2003.
165.
Wahr JA: The use of bovine hemoglobin glutamer-250
(Hemopure) in surgical patients: Results of a multicenter, randomized, single-blinded
trial. Anesth Analg 94:799, 2002.
166.
Engel HL: Medicolegal considerations in blood
transfusion. In Petz LD, Swisher SN (eds): Clinical
Practice of Blood Transfusion, 2nd ed. New York, Churchill Livingstone, 1989, p
355.
167.
Carey JS, Cukingnan RA, Carson E: Transfusion
therapy in cardiac surgery: Impact of the Paul Gann Blood Safety Act in California.
Am Surg 12:830, 1991.
168.
Miller RD: The oxygen dissociation curve and
multiple transfusions of ACD blood. In Howland WS,
Schweizer O (eds): Management of Patients for Radical Cancer Surgery. Clinical
Anesthesia Series, vol 9. Philadelphia, FA Davis, 1972, p. 43.
169.
Myllylä G: New transfusion practice and
haemostasis. Acta Anaesthesiol Scand Suppl 89:76, 1988.
170.
Miller RD: Transfusion therapy and associated
problems. Reg Refresher Course Anesthesiol 1:101, 1973.
